PubHawk
N Engl J Med April 2023 PMID 36877098

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.

Marius M Hoeper, David B Badesch, H Ardeschir Ghofrani, J Simon R Gibbs, Mardi Gomberg-Maitland, Vallerie V McLaughlin, Ioana R Preston, Rogerio Souza, Aaron B Waxman, Ekkehard Grünig, Grzegorz Kopeć, Gisela Meyer, Karen M Olsson, Stephan Rosenkranz, Yayun Xu

Download social card

Mentions

330
Peak: 64 in Apr 2023
across 6 sources since Mar 2023

Extended reach

3,621,783
potential audience

Total likes

596

Video views

9,290

Mentions per month

Mar 2023 – Nov 2025

Where it's discussed

  • X / Twitter196 posts
  • News120 articles
  • Blogs6 articles
  • YouTube4 videos
  • Facebook3 posts
  • Bluesky1 posts

AI synopsis

What people are saying

The discussions demonstrate strong consensus on the promising results of the STELLAR trial, with posts describing sotatercept as 'super exciting,' 'game-changing,' and emphasizing its potential to improve exercise capacity significantly. This tone, along with references to detailed mechanisms and ongoing research, suggests high interest, deep engagement, and a belief in meaningful clinical impact.

AgreementModerate agreement

Most discussions highlight the positive findings and significance of the phase 3 trial, suggesting general agreement on the potential of sotatercept for PAH.

InterestHigh interest

The majority of discussions express high curiosity and enthusiasm, with many posts emphasizing the promising results and new treatment avenues.

EngagementHigh engagement

Posts frequently delve into detailed aspects of the trial, such as mechanisms, adverse events, and potential clinical impact, reflecting deep engagement.

ImpactHigh impact

Widespread mentions of the trial as a 'game changer' and references to clinical guidelines indicate that these discussions perceive the study as having substantial influence on future PAH treatments.

Abstract in brief

  • * A phase 3 clinical trial tested sotatercept against a placebo in adults with PAH who were already on stable therapy, focusing on improvements in exercise capacity measured by walking distance over a 24-week period, along with several secondary health measures.
  • * Results from the trial indicated that patients taking sotatercept had a significant improvement in their 6-minute walk distance compared to those on placebo, showing a median increase of 34.4 meters versus just
Read the full abstract

Top posts

Most liked on X and Bluesky
NEJM
@NEJM · X

Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, disease-associated morbidity and mortality remain high. Read the full STELLAR trial Research Summary: https://t.co/4vBD1CKdhC

Apr 23, 2023 · 161 likes · 45 shares · 935,584 followers View post →
Abdulla A. Damluji, MD, PhD
@DrDamluji · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hypertension space! (Funded by Acceleron Pharma, a subsidiary of MSD) Summary below!

Apr 19, 2023 · 71 likes · 12 shares · 15,804 followers View post →
NEJM
@NEJM · X

Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD1CKL7a #ACC23/#WCCardio https://t.co/CCkHXP0be8

Mar 7, 2023 · 53 likes · 19 shares · 935,584 followers View post →
Diego Segura-Rodríguez
@SeguraCardio · X

Mar 9, 2023 · 37 likes · 14 shares · 25,718 followers View post →
CardioNerds Journal Club
@CardioNerdsJC · X

To get situated: check out this powerful

Aug 31, 2023 · 19 likes · 6 shares · 8,220 followers View post →
Yevgeniy Brailovsky DO MSc FACC
@YevgeniyBr · X

Great Job Nikola Kocovic presenting trial of Sotatercept in PAH. Impressive results on top of concomitant dual and triple therapy patients. Is it time for quadruple therapy? @TJHeartFellows @NEJM @EstefaniaOS @PForfiaPHDOC @anjalivaidyaMD @RyanTedfordMD https://t.co/60HUNRa3qa https://t.co/JQ3IeeVlr8

May 3, 2023 · 17 likes · 5 shares · 2,959 followers View post →

All mentions

Carlos F. Matute-Martínez
@Felipe_Matute · X

STELLAR trial showed that in patients with PAH, sotatercept resulted in a greater improvement in exercise capacity than placebo. https://t.co/I2XYMvTuve

Nov 9, 2025 · 222 followers View post →
Juan Senior
@jsenior64 · X

El primer estudio https://t.co/hTQmddoynM

Oct 1, 2025 · 11,083 followers View post →
Maite Rio
@RrTechu · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Sep 30, 2025 · 13 shares · 734 followers View post →
綿¹⁰⁰%
@LSRFortessa_X20 · X

RT @SHO_ISHIGAKI:

Jul 2, 2025 · 1 share · 726 followers View post →
SHO ISHIGAKI
@SHO_ISHIGAKI · X

Jul 2, 2025 · 5 likes · 1 share · 46 followers View post →
markusathome
@MarkusAtHome · X

Watch also our webinar with Dr. Hoeper from 2023 in

Apr 2, 2025 · 1 like · 109 followers View post →
dough
@semodough · X

RT @WallStPirate: $GOSS Heres the other study I forgot to post with the adverse evens for the Merck drug. https://t.co/LCILdAJSpM

Mar 12, 2025 · 3 shares · 41,088 followers View post →
jeffery Trentkelp
@006Jeffery · X

RT @WallStPirate: $GOSS Heres the other study I forgot to post with the adverse evens for the Merck drug. https://t.co/LCILdAJSpM

Mar 2, 2025 · 3 shares · 236 followers View post →
Damian
@Damian24987160 · X

RT @WallStPirate: $GOSS Heres the other study I forgot to post with the adverse evens for the Merck drug. https://t.co/LCILdAJSpM

Mar 2, 2025 · 3 shares · 76 followers View post →
WallStPirate
@WallStPirate · X

$GOSS Heres the other study I forgot to post with the adverse evens for the Merck drug. https://t.co/LCILdAJSpM

Mar 2, 2025 · 5 likes · 3 shares · 478 followers View post →
UCSF Department of Medicine
@UCSFDOM · X

4/ Why combo therapies upfront? Benefit shown in landmark Ambition Trial @NEJM https://t.co/HNhoBoeoX5 New mechanism: targeting activin signaling pathway w/ sotatercept (SC injection q3 wks) - STELLAR trial @NEJM https://t.co/H0ZGYdn1uf Full treatment algorithm highlights options https://t.co/GtE50YIxX0

Nov 19, 2024 · 2 likes · 1,308 followers View post →
Tomohiro Fujisaki
@TomohiroFujisa2 · X

STELLAR trial. 2023. 日本での承認はまだ　Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | New England Journal of Medicine https://t.co/2wX8RMbtQr

Aug 26, 2024 · 2 likes · 653 followers View post →
Nouf M. BinHumaid
@N000FA · X

My favorite paper from 2023

Jul 2, 2024 · 372 followers View post →
Nouf M. BinHumaid
@N000FA · X

Jul 2, 2024 · 372 followers View post →
Faby G.
@Fabiolaghh · X

RT @mdlizs: Sotatercept for PAH https://t.co/Gl6JhlHAjG ▪️Binds activin and balances vascular homeostasis ▪️Many patients in Phase 3 RCT w…

Apr 7, 2024 · 1 share · 411 followers View post →
mmpp321
@mmpp321 · X

RT @FAPsGal:

Mar 31, 2024 · 2 shares · 348 followers View post →
Neil
@Neil_Mehta · X

The phase 3 study that led to the approval was published in NEJM last year The image shows the improvement in 6 min walk distance in pts on Sotatercept. https://t.co/es48dmLsac 3/4 https://t.co/WWeXHlfAwo

Mar 31, 2024 · 1 like · 5,708 followers View post →
AGUSTINA FERNÁNDEZ
@AgusAgusfar · X

RT @FAPsGal:

Mar 29, 2024 · 2 shares · 559 followers View post →
FAPsGal
@FAPsGal · X

Mar 29, 2024 · 3 likes · 2 shares · 1,370 followers View post →
Dra. R.
@LaDoctoraB · X

RT @tipssovetorax: RECRDAR. Ensayo STELLAR, sotatercept mejoró la capacidad de ejercicio en HAP con tratamiento de base con una mejora de 4…

Mar 29, 2024 · 5 shares · 719 followers View post →
Neumologo Dr
@ppch2302 · X

RT @tipssovetorax: RECRDAR. Ensayo STELLAR, sotatercept mejoró la capacidad de ejercicio en HAP con tratamiento de base con una mejora de 4…

Mar 29, 2024 · 5 shares · 386 followers View post →
Sputnik my love ...
@SputnikMyLove_ · X

RT @tipssovetorax: RECRDAR. Ensayo STELLAR, sotatercept mejoró la capacidad de ejercicio en HAP con tratamiento de base con una mejora de 4…

Mar 29, 2024 · 5 shares · 343 followers View post →
asosaj
@asosaj · X

RT @tipssovetorax: RECRDAR. Ensayo STELLAR, sotatercept mejoró la capacidad de ejercicio en HAP con tratamiento de base con una mejora de 4…

Mar 28, 2024 · 5 shares · 385 followers View post →
Dr. Betulio Chacin
@betuliochacin · X

RT @tipssovetorax: RECRDAR. Ensayo STELLAR, sotatercept mejoró la capacidad de ejercicio en HAP con tratamiento de base con una mejora de 4…

Mar 28, 2024 · 5 shares · 1,146 followers View post →
Sovetorax Tips
@tipssovetorax · X

RECRDAR. Ensayo STELLAR, sotatercept mejoró la capacidad de ejercicio en HAP con tratamiento de base con una mejora de 41 metros en caminada de 6 minutos (6MWD) a la semana 24, así como el natriurético tipo B N-terminal (proBNP NT) y clase funcional-OMS 2 https://t.co/08wvlXQI3J

Mar 28, 2024 · 8 likes · 5 shares · 3,246 followers View post →
Gerard Hough
@GerardHough · X

sotatercept resulted in a greater improvement in exercise capacity than placebo Adverse events that occurred more frequently with sotatercept inc., epistaxis dizziness telangiectasia increased hemoglobin levels thrombocytopenia & increased blood pressure. https://t.co/A6ZaN0KLiW

Feb 29, 2024 · 1,748 followers View post →
Josh Grubbs
@jcgrubbs · X

Exciting news in pulmonary hypertension treatment options! https://t.co/h05poeBStA

Feb 20, 2024 · 2 likes · 239 followers View post →
JorgeEdoChava75
@QicenoJorge · X

RT @InternaHub: @ChiviteDavid Podreu trobar més detalls sobre l'assagi fase 3 de #sotatercept en #PAH: Phase 3 Trial of Sotatercept for Tr…

Feb 18, 2024 · 1 share · 996 followers View post →
Medicina Interna HUB
@InternaHub · X

@ChiviteDavid Podreu trobar més detalls sobre l'assagi fase 3 de #sotatercept en #PAH: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension https://t.co/K3QXkjTF0A

Feb 18, 2024 · 2 likes · 1 share · 168 followers View post →
UTSWRheum
@UTSWRheum · X

#Sotatercept belongs to a new class of drug (selectively inhibits TGF-b) & may be available soon for the treatment of pulmonary arterial hypertension. The drug has been shown to improve exercise capacity. - Dr. S Bartolome #RheumGR @UTSW_LungLadies https://t.co/sxnPrTiriX https://t.co/iZyI4vOMN8

Jan 11, 2024 · 995 followers View post →
Pharmacy Residency
@Phresidency · X

We enjoyed the half-day academic lecture titled “Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension“ presented by Dr. Amal Akhamali, R2 Pharmacy Resident https://t.co/syqM348nA2

Dec 17, 2023 · 1,643 followers View post →
Iridium Continuing Education
@IridiumContEd · X

16/

Oct 31, 2023 · 1 like · 676 followers View post →
Maria Hazel Cohan, DNP, AGACNP-BC, AACC
@mcvhaze · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/aYIqL2MSk3

Oct 13, 2023 · 134 followers View post →
Sasha Prisco, MD, PhD
@SashaPrisco · X

RT @CardioNerdsJC: To get situated: check out this powerful

Sep 1, 2023 · 6 shares · 1,916 followers View post →
Daniel Ambinder, MD
@Dr_DanMD · X

RT @CardioNerdsJC: To get situated: check out this powerful

Aug 31, 2023 · 6 shares · 10,091 followers View post →
Alaa Diab, MD MPH
@DrAlaaDiab · X

RT @CardioNerdsJC: To get situated: check out this powerful

Aug 31, 2023 · 6 shares · 4,511 followers View post →
Maryam Barkhordarian
@MaryamBMD · X

RT @CardioNerdsJC: To get situated: check out this powerful

Aug 31, 2023 · 6 shares · 918 followers View post →
Shivani Hanchate, MD
@HanchateShivani · X

RT @CardioNerdsJC: To get situated: check out this powerful

Aug 31, 2023 · 6 shares · 258 followers View post →
Ryan J Tedford MD
@RyanTedfordMD · X

RT @CardioNerdsJC: To get situated: check out this powerful

Aug 31, 2023 · 6 shares · 9,650 followers View post →
CardioNerds Journal Club
@CardioNerdsJC · X

To get situated: check out this powerful

Aug 31, 2023 · 19 likes · 6 shares · 8,220 followers View post →
ainnadia
@ain8391 · X

RT @cardiomet_CE: 39) A new option for #PAH tx is likely also on the horizon. #Sotatercept is the 1st biologic tx for PAH. It is not yet ap…

Aug 30, 2023 · 2 shares · 284 followers View post →
Reyaj Mikrani
@Reyaj_Mikrani · X

RT @PragueICU:

Aug 19, 2023 · 20 shares · 7 followers View post →
@CKD_ce
@ckd_ce · X

RT @cardiomet_CE: 39) A new option for #PAH tx is likely also on the horizon. #Sotatercept is the 1st biologic tx for PAH. It is not yet ap…

Aug 17, 2023 · 2 shares · 2,637 followers View post →
cardio-met
@cardiomet_CE · X

39) A new option for #PAH tx is likely also on the horizon. #Sotatercept is the 1st biologic tx for PAH. It is not yet approved for use by regulatory agencies, but the recent phase 3 #STELLAR trial convincingly demonstrated efficacy of sotatercept in PAH. https://t.co/qqyftFTrzG https://t.co/ELcSDIOEBr

Aug 16, 2023 · 2 likes · 2 shares · 4,157 followers View post →
pulmmed_ce
@Pulmmed_CE · X

39) A new option for #PAH tx is likely also on the horizon. #Sotatercept is the 1st biologic tx for PAH. It is not yet approved for use by regulatory agencies, but the recent phase 3 #STELLAR trial convincingly demonstrated efficacy of sotatercept in PAH. https://t.co/6CUQcqnUhA https://t.co/vIs8Ve5Dp7

Aug 2, 2023 · 1 like · 488 followers View post →
Amanda Rupert
@amanda_mauder · X

RT @CardioNerdsJC: We hope you enjoyed this journal club as much as we did and looking forward to the next! #CardioNerds Please joing us n…

Jul 29, 2023 · 2 shares · 110 followers View post →
Maryam Barkhordarian
@MaryamBMD · X

RT @CardioNerdsJC: We hope you enjoyed this journal club as much as we did and looking forward to the next! #CardioNerds Please joing us n…

Jul 27, 2023 · 2 shares · 918 followers View post →
CardioNerds Journal Club
@CardioNerdsJC · X

We hope you enjoyed this journal club as much as we did and looking forward to the next! #CardioNerds Please joing us next month to discuss STELLAR trial https://t.co/hYErIqbMRN Follow us for the date to be decided!!

Jul 27, 2023 · 8 likes · 2 shares · 8,220 followers View post →
TJ Doc
@TREVJDOC · X

$GOSS Current MC at $125 million is overvalued to me. There's already a standard of care treatment for type II/III PAH. Torrey trial data isn't great to warrant replacing current care. There's also Sotatercept as competition. I see this going under $1. https://t.co/lf3vOlxOQF

Jun 20, 2023 · 378 followers View post →
Neurona Bipolar
@danifuzetea · X

@todonoticias Está en ensayos de fase 3 el medicamento, y hasta ahora sólo se han hecho experimentos en adultos con tipos específicos de HAP. Esto no es un caso de una droga que “no entra a Argentina” https://t.co/j1Euq5VKQf

Jun 16, 2023 · 2 likes · 15 followers View post →
JustAJerseyGirl
@JustAJerseyGir2 · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Jun 3, 2023 · 12 shares · 4,024 followers View post →
Elizabeth (Liz) Sonntag, MD
@mdlizs · X

Sotatercept for PAH https://t.co/Gl6JhlHAjG ▪️Binds activin and balances vascular homeostasis ▪️Many patients in Phase 3 RCT were on stable PH therapy and GOT EVEN BETTER ▪️Very few adverse events! ▪️Super super exciting and promising for our patients!

May 21, 2023 · 5 likes · 1 share · 5,117 followers View post →
keitam26
@keitam26 · X

RT @cardio_tu: 2 min cardiology（臨床論文、担当：矢尾板信裕） Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med…

May 21, 2023 · 3 shares · 144 followers View post →
Florian Custodis
@floriancustodis · X

RT @gunnar_heine: Himmliches aus Hannover: Prof. Dr. M. Hoeper Bewährtes & Bahnbrechendes zum Lungenhochdruck STELLAR & Pulmonale Hypertoni…

May 19, 2023 · 1 share · 750 followers View post →
Gunnar Henrik Heine
@gunnar_heine · X

Himmliches aus Hannover: Prof. Dr. M. Hoeper Bewährtes & Bahnbrechendes zum Lungenhochdruck STELLAR & Pulmonale Hypertonie Leitlinien @MHH_life @BREATH_Hannover Mit @StephanSchirme1 & Insa Emrich Akademische Partner @oegnephro @dgfn_ev https://t.co/BnIjXniWvF via @YouTube

May 19, 2023 · 1 like · 1 share · 2,326 followers View post →
Florian Custodis
@floriancustodis · X

RT @dgfn_ev: MARKUS@HOMe - diese Woche zur pulmonalen Hypertonie. Wann? Morgen um 19:15 Uhr unter https://t.co/7Dh8mjs1WW

May 18, 2023 · 3 shares · 750 followers View post →
Stephan Schirmer
@StephanSchirme2 · X

RT @dgfn_ev: MARKUS@HOMe - diese Woche zur pulmonalen Hypertonie. Wann? Morgen um 19:15 Uhr unter https://t.co/7Dh8mjs1WW

May 18, 2023 · 3 shares · 8 followers View post →
Gunnar Henrik Heine
@gunnar_heine · X

RT @dgfn_ev: MARKUS@HOMe - diese Woche zur pulmonalen Hypertonie. Wann? Morgen um 19:15 Uhr unter https://t.co/7Dh8mjs1WW

May 18, 2023 · 3 shares · 2,326 followers View post →
Deutsche Gesellschaft für Nephrologie (DGfN) e.V.
@dgfn_ev · X

MARKUS@HOMe - diese Woche zur pulmonalen Hypertonie. Wann? Morgen um 19:15 Uhr unter https://t.co/7Dh8mjs1WW

May 18, 2023 · 7 likes · 3 shares · 657 followers View post →
Hiroyuki Sato 佐藤宏行
@foreverhero0819 · X

RT @cardio_tu: 2 min cardiology（臨床論文、担当：矢尾板信裕） Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med…

May 16, 2023 · 3 shares · 3,765 followers View post →
東北大学 循環器内科
@cardio_tu · X

2 min cardiology（臨床論文、担当：矢尾板信裕） Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2023 Apr 20;388(16):1478-1490. 肺動脈性肺高血圧症に対する新薬ソタテルセプトの第3相試験。

May 15, 2023 · 10 likes · 3 shares · 1,312 followers View post →
FAC
@fac_cardio · X

May 15, 2023 · 3 likes · 6,086 followers View post →
Cristina Mangia MD,MSc,MBA,PhD
@cristinamangia1 · X

RT @PragueICU:

May 13, 2023 · 20 shares · 257 followers View post →
Unidad de Neumología HR
@NeumologiaHR · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/VETPNBpOlM

May 10, 2023 · 1,265 followers View post →
Faby G.
@Fabiolaghh · X

RT @javier20ch: Sotatercept para HAP.

May 6, 2023 · 15 shares · 411 followers View post →
Unidad de Neumología HR
@NeumologiaHR · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/WatqS1iS0B

May 5, 2023 · 1 like · 1,265 followers View post →
Consejo IC HTP
@htp_ic · X

Link full text ⤵️ https://t.co/sExzZBETmI

May 5, 2023 · 1,358 followers View post →
David H. Wiener, MD
@DavidWienerMD · X

RT @YevgeniyBr: Great Job Nikola Kocovic presenting trial of Sotatercept in PAH. Impressive results on top of concomitant dual and triple t…

May 3, 2023 · 5 shares · 7,246 followers View post →
Estefania Oliveros MD
@EstefaniaOS · X

RT @YevgeniyBr: Great Job Nikola Kocovic presenting trial of Sotatercept in PAH. Impressive results on top of concomitant dual and triple t…

May 3, 2023 · 5 shares · 3,067 followers View post →
Patricia Uber
@uber_patricia · X

RT @YevgeniyBr: Great Job Nikola Kocovic presenting trial of Sotatercept in PAH. Impressive results on top of concomitant dual and triple t…

May 3, 2023 · 5 shares · 42 followers View post →
Alexander Hajduczok, MD
@AHajduczok · X

RT @YevgeniyBr: Great Job Nikola Kocovic presenting trial of Sotatercept in PAH. Impressive results on top of concomitant dual and triple t…

May 3, 2023 · 5 shares · 9,519 followers View post →
Jefferson Cardiology Fellows
@TJHeartFellows · X

RT @YevgeniyBr: Great Job Nikola Kocovic presenting trial of Sotatercept in PAH. Impressive results on top of concomitant dual and triple t…

May 3, 2023 · 5 shares · 1,785 followers View post →
Yevgeniy Brailovsky DO MSc FACC
@YevgeniyBr · X

Great Job Nikola Kocovic presenting trial of Sotatercept in PAH. Impressive results on top of concomitant dual and triple therapy patients. Is it time for quadruple therapy? @TJHeartFellows @NEJM @EstefaniaOS @PForfiaPHDOC @anjalivaidyaMD @RyanTedfordMD https://t.co/60HUNRa3qa https://t.co/JQ3IeeVlr8

May 3, 2023 · 17 likes · 5 shares · 2,959 followers View post →
Victor Hernández
@VicHdez27 · X

RT @PragueICU:

Apr 28, 2023 · 20 shares · 140 followers View post →
Jason Weatherald MD
@AlbertaPHdoc · X

RT @respandsleepjc: Join us this Thurs April 13 (tomorrow!) starting at 7pm #rsjc- Article 1: Phase 3 Trial of Sotatercept for Treatmentof…

Apr 28, 2023 · 3 shares · 2,964 followers View post →
Dr A.Hakim Aljawfy
@AljawfyA · X

RT @PragueICU:

Apr 26, 2023 · 20 shares · 216 followers View post →
HospitalBuddy.ie
@HospitalBuddy · X

RT @PragueICU:

Apr 26, 2023 · 20 shares · 1,440 followers View post →
2 Minute Medicine®
@2minmed · X

[4/6] increased hemoglobin levels, dizziness, epistaxis, thrombocytopenia and teleangiectasia. The original study @NEJM can be found here: https://t.co/uY6Iz1rQBL #healthcare #wellness #MedTwitter

Apr 25, 2023 · 5,408 followers View post →
Lung Diseases and Treatment
@lung_diseases · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/8GVWkQeniH #pulmonary #respiratory #lungcancer #treatment #arterial

Apr 25, 2023 · 11 followers View post →
มดแดง
@pu112233445 · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/s0loyGeylD

Apr 24, 2023 · 607 followers View post →
Simon Valentin
@SimonValentinMD · X

RT @LancetRespirMed: In pts w/ pulmonary arterial hypertension who were receiving stable background therapy, sotatercept resulted in a grea…

Apr 24, 2023 · 1 share · 94 followers View post →
Fábio Fonseca
@FbioFon84085623 · X

RT @imedverse: In patients with pulmonary arterial hypertension who were receiving stable background therapy, sotatercept resulted in a gre…

Apr 24, 2023 · 4 shares · 566 followers View post →
The Lancet Respiratory Medicine
@LancetRespirMed · X

In pts w/ pulmonary arterial hypertension who were receiving stable background therapy, sotatercept resulted in a greater improvement in exercise capacity (6MWT) than placebo Read the phase 3 trial in @NEJM here: https://t.co/9rYK6VNNdF

Apr 24, 2023 · 3 likes · 1 share · 25,580 followers View post →
Naloxone
@KhalidW24675290 · X

RT @imedverse: In patients with pulmonary arterial hypertension who were receiving stable background therapy, sotatercept resulted in a gre…

Apr 24, 2023 · 4 shares · 153 followers View post →
Phenomics
@Phenomics_J · X

RT @imedverse: In patients with pulmonary arterial hypertension who were receiving stable background therapy, sotatercept resulted in a gre…

Apr 23, 2023 · 4 shares · 1,523 followers View post →
David Hamilton
@truplistic · X

RT @imedverse: In patients with pulmonary arterial hypertension who were receiving stable background therapy, sotatercept resulted in a gre…

Apr 23, 2023 · 4 shares · 357 followers View post →
Top Biomedical Science
@imedverse · X

In patients with pulmonary arterial hypertension who were receiving stable background therapy, sotatercept resulted in a greater improvement in exercise capacity than placebo. @NEJM #MedEd #MedTwitter #clinicaltrials #research #news https://t.co/JBGzxpqiW4 https://t.co/V2C6yLsXIE

Apr 23, 2023 · 16 likes · 4 shares · 90,463 followers View post →
THOT Consultants
@THOTConsultants · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 442 followers View post →
Iván Arroyo Fernánde
@ArroyoFernande · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 3,084 followers View post →
T.kimura
@jjcrazydiamond · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 1,367 followers View post →
IWASHIMA Satoru岩島覚.MD, PhD.ﾔｰ
@SIwa23288585 · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 1,879 followers View post →
Tatia. Gue
@paraquita · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 49 followers View post →
Bharat Balan, MD, MS
@bharatbalan · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 820 followers View post →
نورة الرويلي Norah
@Noranry11 · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 257 followers View post →
John H. Randall
@JohnHRandall1 · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 44 followers View post →
Dr.Yasser Alwali
@DrYasserAlwali · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 445 followers View post →
Ahmed Ibrahim
@TheIbrahimLab · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 605 followers View post →
Mana
@manasigh · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 330 followers View post →
Guy René BOYER
@grboyer · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 361 followers View post →
bui thanh
@buithan39098090 · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 92 followers View post →
бафомет
@pachekkkko · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 55 followers View post →
NewPhoneWhoThis®
@0GDon · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 32 followers View post →
Sue D’Anna DNP, APRN-BC
@SusieD28a · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 36 followers View post →
ชีน้องดง²⁴
@ponyoboy1997 · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 64 followers View post →
NeoCardioLab - Gabriel Altit
@CardioNeo · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 3,194 followers View post →
MarcHeidorn
@HeidornMarc · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 499 followers View post →
adagajak
@zftjhust · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 214 followers View post →
Jihad M. Chow
@Jihad_7 · X

Sotatercept mejoro las pruebas de ejercicio respiratorio en pacientes con HTP comparado con placebo. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/AKXMZIxKsm

Apr 23, 2023 · 72 followers View post →
TheNeuro
@neuNeuroX · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 1,375 followers View post →
Ricardo Bedón
@ricardo_bedon · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 1,496 followers View post →
Carlos Meza Hernandez
@1997Carlosmeza · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 278 followers View post →
Victor G. Aldana
@vgaldana · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 670 followers View post →
Benedetta Brescia
@BenedettaBres · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 3 followers View post →
Jihad M. Chow
@Jihad_7 · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 72 followers View post →
Ximilgador folklóricu
@mathew_96 · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 520 followers View post →
Sadi Raza, MD FACC
@SadiRazaMD · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 7,875 followers View post →
Pub Health Monitor
@monitor_PH · X

RT @NEJM: Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite the…

Apr 23, 2023 · 45 shares · 1,823 followers View post →
NEJM
@NEJM · X

Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, disease-associated morbidity and mortality remain high. Read the full STELLAR trial Research Summary: https://t.co/4vBD1CKdhC

Apr 23, 2023 · 161 likes · 45 shares · 935,584 followers View post →
John H. Randall
@JohnHRandall1 · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/rxqxMZGDck

Apr 23, 2023 · 44 followers View post →
Tom Hsiung
@TomHsiung · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/45Lpf8LcPZ

Apr 23, 2023 · 462 followers View post →
Sheikh Muhammad Saad
@SM_Saad_7 · X

RT @PragueICU:

Apr 22, 2023 · 20 shares · 23 followers View post →
john morley
@drjohnmorley · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/Hn24KfMbWn

Apr 21, 2023 · 8,327 followers View post →
ガースー＠関節系内科医
@gasu2019koto · X

その辺の経路はよくわからんけどアクチビン受容体IIA-Fc。PAHもバイオの時代か。 Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/mzdMFkC0Mt

Apr 20, 2023 · 2,020 followers View post →
adagajak
@zftjhust · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 214 followers View post →
Gerard
@gerardtp97 · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 14 followers View post →
[Lupinina Lupinus ]
@magutrejo · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 261 followers View post →
Dr.Mughal
@mughal381 · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 1,687 followers View post →
W
@840729m · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 1,563 followers View post →
Carolina Tiraplegui
@Carolina_tgel · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 379 followers View post →
Wassel Sannaa
@wasselsannaa · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 324 followers View post →
Dr. Dacs
@Dan_Collet · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 5,926 followers View post →
IWASHIMA Satoru岩島覚.MD, PhD.ﾔｰ
@SIwa23288585 · X

RT @kirin73934794: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/8jlWXghJAv 肺高血圧にも生物学的製…

Apr 20, 2023 · 1 share · 1,879 followers View post →
Awatif Hafiz , PharmD , BCCP
@awatifhafiz · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 412 followers View post →
عـابـر سـبـيـل
@HaSa08725271 · X

RT @DrDamluji: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hyp…

Apr 20, 2023 · 12 shares · 28 followers View post →
Kaz Ueno
@kirin73934794 · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/8jlWXghJAv 肺高血圧にも生物学的製剤の波がやってきた

Apr 20, 2023 · 3 likes · 1 share · 262 followers View post →
Abdulla A. Damluji, MD, PhD
@DrDamluji · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hypertension space! (Funded by Acceleron Pharma, a subsidiary of MSD) Summary below!

Apr 19, 2023 · 71 likes · 12 shares · 15,804 followers View post →
Prof.Dr.Talat Kılıç
@TalatKl15 · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/aFVV1un8mH

Apr 19, 2023 · 1 like · 156 followers View post →
Prof.Dr.Talat Kılıç
@TalatKl15 · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/SjCgrpKxjI

Mar 27, 2023 · 1 like · 156 followers View post →
The Pulmonary Vascular Research Institute
@PVRI · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: https://t.co/iqtdcU12CQ #Sotatercept #PAH

Mar 23, 2023 · 2,413 followers View post →
Jonas Schupp
@jonas_schupp · X

@MHH_life @NEJM Clinical practice changing study! It feels like to beginning of a new era for PAH patients! Congrats to Karen & Marius & team!!! Here's the link to the publication: https://t.co/xzkKQNYfcP

Mar 20, 2023 · 2 likes · 327 followers View post →
@IM_Crit_
@imcrit.bsky.social · Bluesky

https://www.nejm.org/doi/full/10.1056/NEJMoa2203478 https://www.nejm.org/doi/full/10.1056/NEJMoa2213558?query=recirc_curatedRelated_article

Mar 18, 2023 · 1 share View post →
Tom
@youareinformed · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension https://t.co/KEysWfaa3x

Mar 15, 2023 · 3,278 followers View post →
Faby G.
@Fabiolaghh · X

RT @SeguraCardio:

Mar 15, 2023 · 14 shares · 411 followers View post →
CardioTwit
@Goli_Bot · X

RT @SeguraCardio:

Mar 13, 2023 · 14 shares · 163 followers View post →
Professor M Z Khalil
@mzkhalil · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM PS. Sotatercept is a fusion protein that traps activins and growth differentiation factors involved in pulmonary arterial hypertension. https://t.co/XTsZOVkdDh https://t.co/lYK7iy12vl

Mar 10, 2023 · 2 likes · 2,854 followers View post →
Bayar Jaff
@JaffBayar · X

RT @SeguraCardio:

Mar 10, 2023 · 14 shares · 605 followers View post →
CNCFCardio
@CNCFCardio · X

RT @SeguraCardio:

Mar 10, 2023 · 14 shares · 5,285 followers View post →
Adrian Lozano
@adrianenrique25 · X

RT @SeguraCardio:

Mar 10, 2023 · 14 shares · 895 followers View post →
EOLO MORANDI JR.
@eolojr · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 539 followers View post →
UKCPA Cardiovascular Committee
@UKCPACardiac · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 761 followers View post →
Santiago Rivadeneira
@santiagorivade7 · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 82 followers View post →
Luis Zurita G.
@LuisZuritaG · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/AQK0zbYl9h

Mar 9, 2023 · 3 likes · 1 share · 6,433 followers View post →
Michael Buratovich
@MichaelBuratovi · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 1,163 followers View post →
SA
@drsaeedayed · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 31 followers View post →
Ketan Khadse
@ketan79797 · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 126 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 32,538 followers View post →
MercheRC
@rc_merche · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 312 followers View post →
Emilia Martinez
@emartinezgmg · X

RT @SeguraCardio:

Mar 9, 2023 · 14 shares · 1,010 followers View post →
Diego Segura-Rodríguez
@SeguraCardio · X

Mar 9, 2023 · 37 likes · 14 shares · 25,718 followers View post →
Jaroslav Novotný
@novotnyjarosl · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 9, 2023 · 19 shares · 612 followers View post →
Momen Banifadel, MD, MPH
@mbanifa1 · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 8, 2023 · 19 shares · 232 followers View post →
the paper link
@the_paper_link · X

Trend new: Hoeper MM, ..., Stellar Trial Investigators (N Engl J Med) __Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension__ https://t.co/9g1XyqDirf

Mar 7, 2023 · 138 followers View post →
Dr Ramdas Pananthattil
@PananthattilR · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 794 followers View post →
Rodrigo Torres Castro
@klgorodtorres · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 2,152 followers View post →
Daniel Coyne
@DrDanMO · X

Sotatercept is a fusion protein Activin trap. Increased Activin occurs in CKD and may contribute to vasc dz and anemia. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/TsznX2Cfli

Mar 7, 2023 · 6 likes · 3,446 followers View post →
Joan Albert Barberà
@J_AlbertBarbera · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 1,270 followers View post →
Tess
@maritess_mt · X

RT @wginsing: Pleased to see that the full results have been published - Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial…

Mar 7, 2023 · 1 share · 1,605 followers View post →
Raquel Rozdolski
@RaquelRozdolski · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension https://t.co/IjLDZMoc62

Mar 7, 2023 · 17 followers View post →
Hiroyuki Sato 佐藤宏行
@foreverhero0819 · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 3,765 followers View post →
Rene Sugar
@renesugar · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension https://t.co/yYP1qbsIeU

Mar 7, 2023 · 3,952 followers View post →
Drug Facts
@RX_facts · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 29 followers View post →
serrgv
@serrgv · X

RT @medical_xpress: Adding sotatercept to existing therapy shows promise in treating rare heart-lung condition @nejm https://t.co/AjdaSdJpX…

Mar 7, 2023 · 7 shares · 148 followers View post →
Geyser of Unique Idea
@shell_salon · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 10 followers View post →
Silvio A. Ñamendys-Silva
@snamendys · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 3,696 followers View post →
Patrick Mercié
@MerciePatrick · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 1,341 followers View post →
Durga Prasanna Misra
@DurgaPrasannaM1 · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 2,335 followers View post →
Cher ባንቄ
@tsebank · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 49 followers View post →
inesponz
@inesponz · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 105 followers View post →
Juanmarcosgg
@juanmarcosgg · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 510 followers View post →
Pub Health Monitor
@monitor_PH · X

RT @NEJM: Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD…

Mar 7, 2023 · 19 shares · 1,823 followers View post →
NEJM
@NEJM · X

Original Article: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (STELLAR trial) https://t.co/4vBD1CKL7a #ACC23/#WCCardio https://t.co/CCkHXP0be8

Mar 7, 2023 · 53 likes · 19 shares · 935,584 followers View post →
Manu Gupta
@guptam108 · X

RT @medical_xpress: Adding sotatercept to existing therapy shows promise in treating rare heart-lung condition @nejm https://t.co/AjdaSdJpX…

Mar 7, 2023 · 7 shares · 1,097 followers View post →
stelios dermousis
@steder74 · X

RT @medical_xpress: Adding sotatercept to existing therapy shows promise in treating rare heart-lung condition @nejm https://t.co/AjdaSdJpX…

Mar 7, 2023 · 7 shares · 1,549 followers View post →
Phys.org
@physorg_com · X

RT @medical_xpress: Adding sotatercept to existing therapy shows promise in treating rare heart-lung condition @nejm https://t.co/AjdaSdJpX…

Mar 7, 2023 · 7 shares · 1,024,085 followers View post →
Science X
@sciencex_com · X

RT @medical_xpress: Adding sotatercept to existing therapy shows promise in treating rare heart-lung condition @nejm https://t.co/AjdaSdJpX…

Mar 7, 2023 · 7 shares · 3,527 followers View post →
Medical Xpress
@physorg_health · X

RT @medical_xpress: Adding sotatercept to existing therapy shows promise in treating rare heart-lung condition @nejm https://t.co/AjdaSdJpX…

Mar 7, 2023 · 7 shares · 7,110 followers View post →
Medical Xpress
@medical_xpress · X

Adding sotatercept to existing therapy shows promise in treating rare heart-lung condition @nejm https://t.co/AjdaSdJpXK https://t.co/lhopgGJSTb

Mar 7, 2023 · 13 likes · 7 shares · 172,922 followers View post →
wendy gin-sing
@wginsing · X

Pleased to see that the full results have been published - Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/f7meiZo9W4

Mar 6, 2023 · 7 likes · 1 share · 741 followers View post →
Strong_bio
@strong_bio · X

RT @BertrandBio: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension $MRK | NEJM https://t.co/3801fntqfO https://…

Mar 6, 2023 · 2 shares · 82 followers View post →
renalRCTs
@renalRCTs · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension https://t.co/Hj8bMUOTaS https://t.co/aCALHS2Nm7

Mar 6, 2023 · 39 followers View post →
Fix News Peak
@fix_newspeak · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM - https://t.co/vIRovKNnXH https://t.co/69WLRSjIJQ #TrendingNow #HotTopics #Trending #News #NewsUpdate #Forumidex #MyForumLink

Mar 6, 2023 · 795 followers View post →
Abdelhamid Hamdy
@abdelhamed012 · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/qEikHCvh86

Mar 6, 2023 · 3,301 followers View post →
Christina Chrysohoou
@chrysohoou · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM https://t.co/jH4O22Uw2K .. QoL only..

Mar 6, 2023 · 1 like · 477 followers View post →
Nouf M. BinHumaid
@N000FA · X

Results are up

Mar 6, 2023 · 372 followers View post →
bigmikehands
@bigmikehands · X

RT @BertrandBio: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension $MRK | NEJM https://t.co/3801fntqfO https://…

Mar 6, 2023 · 2 shares · 75 followers View post →
Manuel Gracián
@ManuelGracian · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM ⁦@carlos_sierra⁩ ⁦@jsmadero⁩ ⁦@germanfajardo⁩ ⁦@internalincmnsz⁩ ⁦@Geriatriamexico⁩ ⁦@INCMNSZ_Geria⁩ https://t.co/ZoUNYh8ODI

Mar 6, 2023 · 1 like · 3,141 followers View post →
Bertrand Delsuc
@BertrandBio · X

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension $MRK | NEJM https://t.co/3801fntqfO https://t.co/OYjH5mi2qS

Mar 6, 2023 · 2 likes · 2 shares · 18,778 followers View post →